MIRA INFORM REPORT

 

 

Report Date :

04.02.2014

 

IDENTIFICATION DETAILS

 

Name :

ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED

 

 

Formerly Known As :

ZYDUS MAYNE ONCOLOGY PRIVATE LIMITED

 

 

Registered Office :

Plot No.3, Pharmez, Special Economic Zone, Sarkhej Bavla Highway, (N. H. No.8-A), Village Matoda, Taluka Sanand – 382210, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

13.06.2005

 

 

Com. Reg. No.:

04-046246

 

 

Capital Investment / Paid-up Capital :

Rs.150.000 Millions

 

 

CIN No.:

[Company Identification No.]

U24230GJ2005PTC046246

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

AHMZ00175A

 

 

PAN No.:

[Permanent Account No.]

AAACZ2327A

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceutical Products.

 

 

No. of Employees :

Information denied by the management

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (66)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 12030000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a joint venture between cadila healthcare limited and merge.

 

It is an established company having fine track record. Financial position of the company appears sound. Fundamentals of the company’s are strong and healthy. Performance capability of the company is high.

 

Trade relations are fair. Business is active. Payments are reported to be regular and as per commitment.

 

The company can be considered good for normal business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

INDIAN ECONOMIC OVERVIEW

 

The services sector, the largest contributor to India’s GDP, contracted for the sixth consecutive month in December, as orders dipped. However, hiring has risen.  Direct tax collections rose 12.3 % during the April – December period of the current financial year.  The government has decided to retain 100 per cent foreign direct investment in both greenfield (new) and brown field (existing) pharmaceutical companies, despite concerns over genetic drugs going out of production, if multi-national companies take over domestic ones. In M&A deals, a non compete clause would not be allowed, except in special circumstances. The Department of Industrial Policy and Promotion plans to release the next edition of its consolidated foreign direct investment policy document on March 31, incorporating changes made in the past year. DIPP compiles all policies related to India’s FDI regime into a single document to make it easy for investors to understand. 185 million estimated number of mobile internet users in India by June 2014, according to a report by the Internet & Mobile Association of India and IMRB International.  India had 110 million mobile internet users with 25 million in rural areas. $3.77 tn estimated global IT spending in 2014, according to research firm Gartner Inc. The growth forecast for this year is cut to 3.1 %from the earlier estimate of 3.5 %. The spending growth forecast for telecom services – a segment that accounts for more than 40 % at total IT spending – from 1.9 per cent to 1.2 per cent is the main reason for this overall IT cut. A Reserve Bank of India committee has recommended setting up a special category of lenders who would cater to small businesses and households, to expand the number of customers with access to banking services. These banks would focus onproviding payment services and deposit products.  Indian banks want the free use of automated teller machines to be capped at five transactions in a month including that of the bank in which the account is active. This follows state government order to banks to install security guards at ATM booths after a woman banker was assaulted in Bangalore. The government is likely to present a vote on Account in mid-February. The annual Economic Survey will be tabled later in Parliament along with the full Budget. A full Budget for 2014/15 is likely to be present in July by the new government formed after the General Election. The government will soon launch an internet spy system, called Netra, to detect malafide messages. Security agency will deploy the system to capture dubious voice traffic on applications such as Skype and Google Talk, as well as tweeters.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long term rating (AA-)

Rating Explanation

High degree of safety and carry very low credit risk.

Date

December 27, 2012

 

 

Rating Agency Name

CRISIL

Rating

Short term rating A1+

Rating Explanation

Strongest degree of safety and carry lowest credit risk.

Date

December 27, 2012

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

 

 

INFORMATION DENIED BY

 

Name :

Mr. Jayesh Patel

Designation :

Finance Department

Contact No.:

91-2717-663000 / 106

Date :

04.02.2014

 

 

LOCATIONS

 

Registered Office :

Plot No.3, Pharmez, Special Economic Zone, Sarkhej Bavla Highway, (N. H. No.8-A), Village Matoda, Taluka Sanand – 382210, Gujarat, India

Tel. No.:

91-2717-663000/ 663211 / 106

Mobile No.:

91-9724307940 (Mr. Jayesh Patel)

91-9974051445 (Mr. Deepak B. Acharya)

Fax No.:

91-2717-663100

E-Mail :

contact@zydushospira.com

jayeshpatel@zydushospira.com

contact@zydusmayne.com

 

 

DIRECTORS

 

As on 02.05.2013

 

Name :

Mr. Omprakash R. Arya

Designation :

Managing Director

Address :

12, Ishan Apartments, Brahmin Mitra Mandal Society, Ellisbridge, Ahmedabad – 380006, Gujarat, India

Date of Birth/Age :

01.03.1950

Qualification

M. Sc.

Experience :

34 years

Date of Appointment :

01.02.2006

DIN No. ;

00146677

 

 

Name :

Mr. Arthur J. Flocco JR

Designation :

Director

Address :

305, Meadow Lake Lane, Lake Forest, Illionis IL60045, USA

Date of Birth/Age :

12.08.1957

Date of Appointment :

22.07.2009

DIN No. :

02634539

 

 

Name :

Mr. Ganesh N. Nayak

Designation :

Director

Address :

3, Ashwamegh Part V, Jodhpur, Satelite Road, Ahmedabad – 380015, Gujarat, India

Date of Birth/Age :

18.05.1955

Date of Appointment :

24.01.2006

Din No. :

00017481

 

 

Name :

Mr. Shirtishkumar G. Belapure

Designation :

Director

Address :

3, Amramanjari Bungalow, Opposite Chitvan Plor, Gala Club Road, Bopal – 380058, Gujarat, India

Date of Birth/Age :

19.07.1953

Date of Appointment :

16.07.2008

DIN No. :

02219458

 

 

Name :

Mr. Canakapalli B. Rao

Designation :

Director

Address :

No.9, Old No.6, Lakshmanan Street, Mahalingapuram, Nungambakkam, Chennai – 600034, Tamilnadu, India

Date of Birth/Age :

10.08.1949

Date of Appointment :

15.04.2010

DIN No. :

00010175

 

 

Name :

Richard John Davies

Designation :

Director

Address :

331, Sheridan Road, Winnetka IL U.S - 600934227

Date of Birth/Age :

26.06.1961

Date of Appointment :

02.05.2013

DIN No. :

06568148

 

 

KEY EXECUTIVES

 

Name :

Mr. Umesh Parikh

Designation :

Vice President and Company Secretary

Date of Birth/Age :

42 years

Qualification

ICWA/ CS

Experience :

21 years

Date of Appointment :

17.11.2005

PAN No. : 

ACCPP4496R

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 02.05.2013

 

Names of Shareholders

No. of Shares

Hospira Australia Pty Limited, Australia

7500000

Cadila Healthcare Limited, India

7500000

 

 

Total

15000000

 


As on 02.05.2013

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage of Holding

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

50.00

Bodies corporate

50.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceutical Products.

 

 

Products :

Item Code No. (ITC Code)

Product Description

30049044

Docetaxel

30049049

Other Anticencer Formulation

 

 

GENERAL INFORMATION

 

No. of Employees :

Information denied by the management

 

 

Bankers :

·         Bank of Baroda

Ashram Road Branch, Near Vallabh Sadan, Ahmedabad – 390009, Gujarat, India

 

·         ICICI Bank Limited

Landmark Race Cource Circle, Alkapuri, Baroda – 390015, Gujarat, India

 

Banking Relations :

--

 

 

Auditors :

 

Name :

B S R and Company

Chartered Accountants

Address :

Lodha Excelus, 1st, Floor, Apollo mills compound, N M Joshi Marg, Mahalaxmi, Mumbai – 400011, Maharashtra, India

PAN No. :

AAAFB9852F

 

 

Joint Ventures :

·         Cadila Healthcare Limited, Australia

·         Hospira Australia Pty Limited, India

 


 

CAPITAL STRUCTURE

 

As on 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

15000000

Equity Shares

Rs.10/- each

Rs.150.000  Millions

5000

Preference Shares

Rs. 100000/- each

Rs.500.000  Millions

 

 

 

 

 

Total

 

Rs.650.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

15000000

Equity Shares

Rs.10/- each

Rs.150.000 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

150.000

150.000

550.000

(b) Reserves & Surplus

2859.830

3088.550

661.530

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

3009.830

3238.550

1211.530

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

0.000

0.000

18.520

(c) Other long term liabilities

1.280

0.280

0.000

(d) long-term provisions

7.560

6.900

3.390

Total Non-current Liabilities (3)

8.840

7.180

21.910

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

113.550

142.120

104.480

(c) Other current liabilities

31.580

47.090

490.740

(d) Short-term provisions

3952.650

104.150

2704.650

Total Current Liabilities (4)

4097.780

293.360

3299.870

 

 

 

 

TOTAL

7116.450

3539.090

4533.310

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

646.020

685.770

732.550

(ii) Intangible Assets

7.090

8.930

10.950

(iii) Capital work-in-progress

113.010

28.690

2.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

77.610

32.440

2.510

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

843.730

755.830

748.010

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

1596.330

60.780

0.000

(b) Inventories

533.700

560.840

652.970

(c) Trade receivables

1298.450

1619.830

2919.790

(d) Cash and cash equivalents

2816.690

526.290

202.930

(e) Short-term loans and advances

14.520

10.780

9.610

(f) Other current assets

13.030

4.740

0.000

Total Current Assets

6272.720

2783.260

3785.300

 

 

 

 

TOTAL

7116.450

3539.090

4533.310

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

 

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Income

 

 

 

Other Income

 

 

 

 

 

TOTAL                                    

6901.270

5928.200

4446.690

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

 

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                    

2147.520

1418.930

1441.820

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

4753.750

4509.270

3004.870

 

 

 

 

 

Less

FINANCIAL EXPENSES                        

3.830

21.470

7.267

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

4749.920

4487.800

2997.603

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION        

80.670

74.870

73.326

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

4669.250

4412.930

2924.277

 

 

 

 

 

Less

TAX                                                                 

934.190

870.170

9.673

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

3735.060

3542.760

2914.604

 

 

 

 

 

 

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

2042.810

370.077

446.782

 

 

 

 

 

 

APPROPRIATIONS

 

 

 

 

 

Transfer to General Reserve

0.000

354.280

291.460

 

 

Dividend

0.000

960.000

2323.000

 

 

Tax on Dividend

0.000

155.740

4.542

 

 

Transfer to capital redemption reserves

0.000

400.000

0.000

 

BALANCE CARRIED TO THE B/S

5777.870

2042.810

370.077

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

249.00

236.18

192.14

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

54.12

59.76

65.54

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

66.67

125.71

64.53

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

1.55

1.36

2.41

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.00

0.00

0.00

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.53

9.49

1.15

 

 

LOCAL AGENCY FURTHER INFORMATION

 

NOTE: Current Maturities of Long Term Debts is Not Available.

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

NOTE:

 

The Registered Office of the company has been shifted from, Zydus Tower Satellite cross Road, Sarkhej Gandhi Nagar Highway, Ahmedabad – 380015, Gujarat, India, to the present address w.e.f. 19.07.2007.

 

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10211370

23/03/2010

235,000,000.00

STANDARD CHARTERED BANK

H2 CONNAUGHT CIRCUS, NEW DELHI, Delhi - 110001, INDIA

A82640848

2

10061027

04/08/2010 *

300,000,000.00

BANK OF BARODA

ASHRAM ROAD BRANCH, NEAR VALLABH SADAN, AHMEDABAD, Gujarat - 390009, INDIA

A91222984

3

10040214

04/08/2010 *

300,000,000.00

BANK OF BARODA

ASHRAM ROAD BRANCH, NEAR VALLABH SADAN, AHMEDABAD, Gujarat - 390009, INDIA

A91222901

4

10041518

13/08/2010 *

850,000,000.00

BANK OF BARODA

ASHRAM ROAD BRANCH, NEAR VALLABH SADAN, AHMEDABAD, Gujarat - 390009, INDIA

A93726420

 

* Date of charge modification

 

 

BACKGROUND

 

The Company is a Joint Venture between Cadila Healthcare Limited and Hospira Australia Pty Limited, incorporated in Australia. The Company is manufacturing anti-cancer formulations in Pharmez, Special Economic Zone near Ahmedabad. The Company had started the commercial production on 1 May 2009.

 

 

FIXED ASSETS

 

˛      Land

˛      Buildings

˛      Plant and Equipment

˛      Furniture and Fixtures

˛      Vehicles

˛      Office equipment

˛      Computer Equipments

 

 

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.69

UK Pound

1

Rs.102.97

Euro

1

Rs.84.58

 

 

INFORMATION DETAILS

 

Information Gathered by :

PDT

 

 

Report Prepared by :

ANK

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

7

PAID-UP CAPITAL

1~10

7

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

8

--PROFITABILIRY

1~10

8

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

7

--RESERVES

1~10

8

--CREDIT LINES

1~10

7

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

66

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.